Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders)
  4. Volume 25, Issue 2
  5. Article
Volume 25, Issue 2
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Infectious disorders known as Neglected Tropical Diseases (NTDs) initially affect the world's underprivileged citizens. They have been disregarded for many years, first as a result of a general indifference to such a developing world and, more recently, as an outcome of the intense attention on AIDS, TB, and malaria. Tropical diseases mostly affect the region where health and hygiene are sacrificed, and most of the population lacks access to sufficient food and living resources. WHO has drafted and released the directions for regulation, prevention, and successful eradication of NTDs as per the revised roadmap of 2021-2030. This shifts from vertical disease programs to integrated cross-cutting methods. In the current work, we have provided comprehensive information on various aspects of neglected tropical diseases, including the clinical management of NTDs. This encompasses the causative agent of the diseases, their symptoms, pathogenesis, diagnosis, treatment, prognosis, and epidemiological perspective of major NTDs. This review will shed light on several perspectives of NTDs having influential roles in proposing strategies to control and treat them around the world.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265305007240718081727
2024-08-23
2025-01-01

  • From This Site

    /content/journals/iddt/10.2174/0118715265305007240718081727
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HotezP.J. AksoyS. BrindleyP.J. KamhawiS. What constitutes a neglected tropical disease?PLoS Negl. Trop. Dis.2020141e000800110.1371/journal.pntd.0008001 31999732
     [Google Scholar]
  2. HotezP.J. NTDs V.2.0: “blue marble health”--neglected tropical disease control and elimination in a shifting health policy landscape.PLoS Negl. Trop. Dis.2013711e257010.1371/journal.pntd.0002570 24278496
     [Google Scholar]
  3. HotezP.J. KamathA. Neglected tropical diseases in sub-saharan africa: Review of their prevalence, distribution, and disease burden.PLoS Negl. Trop. Dis.200938e41210.1371/journal.pntd.0000412
     [Google Scholar]
  4. HotezP.J. "A plan to defeat neglected tropical diseases".Sci. Am.20103021909410.1038/scientificamerican0110‑90
     [Google Scholar]
  5. "World Health Organization". World Health Organization".2017
     [Google Scholar]
  6. MalecelaM.N. DuckerC. A road map for neglected tropical diseases 2021–2030.Trans. R. Soc. Trop. Med. Hyg.2021115212112310.1093/trstmh/trab002 33508095
     [Google Scholar]
  7. GBD 2013 mortality causes of death collaborators (2015). “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013".Lancet2015385996311717110.1016/S0140‑6736(14)61682‑2
     [Google Scholar]
  8. ManryJ. Human genetics of Buruli ulcer.Hum. Genet.20201396-784785310.1007/s00439‑020‑02163‑1 32266523
     [Google Scholar]
  9. MonteiroF.A. WeirauchC. FelixM. LazoskiC. Abad-FranchF. Evolution, systematics, and biogeography of the triatominae, vectors of chagas disease.Adv. Parasitol.20189926534410.1016/bs.apar.2017.12.002 29530308
     [Google Scholar]
  10. GarrettK.B. BoxE.K. ClevelandC.A. MajewskaA.A. YabsleyM.J. Dogs and the classic route of guinea worm transmission: An evaluation of copepod ingestion.Sci. Rep.2020101143010.1038/s41598‑020‑58191‑4
     [Google Scholar]
  11. Del BruttoO.H. GarcíaH.H. Taenia solium Cysticercosis — The lessons of history.J. Neurol. Sci.20153591-239239510.1016/j.jns.2015.08.011 26320098
     [Google Scholar]
  12. Siles-LucasM. CasulliA. CirilliR. CarmenaD. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.PLoS Negl. Trop. Dis.2018124e000642210.1371/journal.pntd.0006422
     [Google Scholar]
  13. AksoyD.Y. KerimogluU. OtoA. Infection with fasciola hepatica.Clin. Microbiol. Infect.2005111185986110.1111/j.1469‑0691.2005.01254.x 16216098
     [Google Scholar]
  14. SchmidtR.S. MacêdoJ.P. SteinmannM.E. Transporters of Trypanosoma brucei —phylogeny, physiology, pharmacology.FEBS J.201828561012102310.1111/febs.14302 29063677
     [Google Scholar]
  15. OkworI. UzonnaJ. Social and economic burden of human leishmaniasis.Am. J. Trop. Med. Hyg.201694348949310.4269/ajtmh.15‑0408 26787156
     [Google Scholar]
  16. Sugawara-MikamiM. TanigawaK. KawashimaA. Pathogenicity and virulence of Mycobacterium leprae.Virulence20221311985201110.1080/21505594.2022.2141987 36326715
     [Google Scholar]
  17. SmallS.T. TischD.J. ZimmermanP.A. Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti.Infect. Genet. Evol.201428334310.1016/j.meegid.2014.08.018 25176600
     [Google Scholar]
  18. FahalA.H. Mycetoma: A thorn in the flesh.Trans. R. Soc. Trop. Med. Hyg.200498131110.1016/S0035‑9203(03)00009‑9 14702833
     [Google Scholar]
  19. ElgartM.L. Onchocerciasis and dracunculosis.Dermatol. Clin.19897232333010.1016/S0733‑8635(18)30603‑X 2527659
     [Google Scholar]
  20. NormanF.F. ComecheB. ChamorroS. López-VélezR. Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants.Expert Rev. Anti Infect. Ther.202018212714310.1080/14787210.2020.1713099 31914335
     [Google Scholar]
  21. AndersonR. TruscottJ. HollingsworthT.D. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths.Philos. Trans. R. Soc. Lond. B Biol. Sci.201436916452013043510.1098/rstb.2013.0435
     [Google Scholar]
  22. LietmanT.M. PinsentA. LiuF. DeinerM. HollingsworthT.D. PorcoT.C. Models of trachoma transmission and their policy implications: From control to elimination.Clin. Infect. Dis.201866Suppl. 4S275S28010.1093/cid/ciy004 29860288
     [Google Scholar]
  23. LeeT.H. LeeL.K. LyeD.C. LeoY.S. Current management of severe dengue infection.Expert Rev. Anti Infect. Ther.2017151677810.1080/14787210.2017.1248405 27786589
     [Google Scholar]
  24. HurtJ.B. MadayK.R. Management and treatment of animal bites.JAAPA2018314273110.1097/01.JAA.0000531049.59137.cd 30973531
     [Google Scholar]
  25. "Trypanosomiasis, human African (sleeping sickness)"www.who.int
  26. SimarroP.P. CecchiG. FrancoJ.R. Estimating and mapping the population at risk of sleeping sickness.PLoS Negl. Trop. Dis.2012610e185910.1371/journal.pntd.0001859 23145192
     [Google Scholar]
  27. KagbadounoM.S. CamaraM. RouambaJ. Epidemiology of sleeping sickness in boffa (Guinea): Where are the trypanosomes?PLoS Negl. Trop. Dis.2012612e194910.1371/journal.pntd.0001949 23272259
     [Google Scholar]
  28. MugenyiA. MuhanguziD. HendrickxG. Spatial analysis of G.f.fuscipes abundance in uganda using poisson and zero-inflated poisson regression models.PLoS Negl. Trop. Dis.20211512e000982010.1371/journal.pntd.0009820
     [Google Scholar]
  29. VosT. AllenC. AroraM. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015.Lancet2016388100531545160210.1016/S0140‑6736(16)31678‑6 27733282
     [Google Scholar]
  30. Trypanosomiasis, human African (sleeping sickness). World Health Organization. 2014Available from: https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness)
  31. SimarroP. FrancoJ. DiarraA. JanninJ. Epidemiology of human African trypanosomiasis.Clin. Epidemiol.2014625727510.2147/CLEP.S39728 25125985
     [Google Scholar]
  32. OloweS.A. A case of congenital trypanosomiasis in Lagos.Trans. R. Soc. Trop. Med. Hyg.1975691575910.1016/0035‑9203(75)90011‑5 1170654
     [Google Scholar]
  33. RochaG. MartinsA. GamaG. BrandãoF. AtouguiaJ. Possible cases of sexual and congenital transmission of sleeping sickness.Lancet2004363940424710.1016/S0140‑6736(03)15345‑7 14738812
     [Google Scholar]
  34. CherenetT. SaniR.A. PanandamJ.M. NadzrS. SpeybroeckN. Van den BosscheP. Seasonal prevalence of bovine trypanosomosis in a tsetse-infested zone and a tsetse-free zone of the Amhara Region, north-west Ethiopia.Onderstepoort J. Vet. Res.200471430731210.4102/ojvr.v71i4.250 15732457
     [Google Scholar]
  35. CornfordE.M. BocashW.D. BraunL.D. CraneP.D. OldendorfW.H. MacInnisA.J. Rapid distribution of tryptophol (3-indole ethanol) to the brain and other tissues.J. Clin. Invest.19796361241124810.1172/JCI109419 447842
     [Google Scholar]
  36. LundkvistG.B. KristenssonK. BentivoglioM. Why trypanosomes cause sleeping sickness.Physiology (Bethesda)200419419820610.1152/physiol.00006.2004 15304634
     [Google Scholar]
  37. "CDC - African Trypanosomiasis - Disease"2020Available from: www.cdc.gov
  38. TrucP. LejonV. MagnusE. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in west and central africa.Bull. World Health Organ.20028011882886 12481210
     [Google Scholar]
  39. "Fexinidazole, the first all-oral treatment for sleeping sickness, approved in democratic republic of congo – DNDi"Available from: www.dndi.org
  40. LutjeV. SeixasJ. KennedyA. Chemotherapy for second-stage human african trypanosomiasis.Cochrane Libr.201320136CD00620110.1002/14651858.CD006201.pub3 23807762
     [Google Scholar]
  41. World health organization.In: World Health Report 2000.Health Systems Improving Performance. Geneva2000
     [Google Scholar]
  42. FrancoJ.R. CecchiG. PriottoG. Monitoring the elimination of human African trypanosomiasis: Update to 2014.PLoS Negl. Trop. Dis.2017115e000558510.1371/journal.pntd.0005585 28531222
     [Google Scholar]
  43. World health organizationTrypanosomiasis, human African (sleeping sickness).Geneva: World Health Organization2023
     [Google Scholar]
  44. World Health Organization. Report of the third WHO stakeholders meeting on gambiense human African trypanosomiasis elimination20201820
     [Google Scholar]
  45. RoyM. RawatA. KaushikS. JyotiA. SrivastavaV.K. 2022; Endogenous cysteine protease inhibitors in upmost pathogenic parasitic protozoa.Microbiol. Res.202226112706110.1016/j.micres.2022.127061
     [Google Scholar]
  46. RawatA. RoyM. JyotiA. KaushikS. VermaK. SrivastavaV.K. Cysteine proteases: Battling pathogenic parasitic protozoans with omnipresent enzymes.Microbiol. Res.202124912678410.1016/j.micres.2021.126784 33989978
     [Google Scholar]
  47. Leishmaniasis Fact sheet N°375In: World Health Organization2014
     [Google Scholar]
  48. BarrettM.P. CroftS.L. Management of trypanosomiasis and leishmaniasis.Br. Med. Bull.2012104117519610.1093/bmb/lds031 23137768
     [Google Scholar]
  49. MylerPJ FaselN Caister Academic Press. 2008Leishmania: After. The Genome.
     [Google Scholar]
  50. DacieJ.V. BainB.J. BatesI. Dacie and Lewis practical hematology.PhiladelphiaChurchill Livingstone/Elsevier2006
     [Google Scholar]
  51. CustodioE. López-AlcaldeJ. HerreroM. Nutritional supplements for patients being treated for active visceral leishmaniasis.Cochrane Libr.201820183CD01226110.1002/14651858.CD012261.pub2 29578237
     [Google Scholar]
  52. AlexanderB. MaroliM. Control of phlebotomine sandflies.Med. Vet. Entomol.200317111810.1046/j.1365‑2915.2003.00420.x 12680919
     [Google Scholar]
  53. "Leishmaniasis: Situation and trends"In: WHO Global Health Observatory.2018
     [Google Scholar]
  54. "Leishmaniasis: Magnitude of the problem".In: World Health Organization.2013
     [Google Scholar]
  55. "Hope for tropical disease vaccine".In: BBC News.2006
     [Google Scholar]
  56. "Informes informe de fronteras febrero 2005".In: Servicio Jesuita a Refugiados2005
     [Google Scholar]
  57. KennedyK. 2010.VCS advocacy in the news: VA may designate 9 infectious diseases as related to gulf warIn: Veterans for Common Sense.2011
     [Google Scholar]
  58. "Business: Company's mesh will help troops beat 'Baghdad boils'".In: 2005
     [Google Scholar]
  59. BhatiaS. GoliD. Leishmaniasis: Biology, Control and New Approaches for Its Treatment.CRC Press201610.1201/9781315366111
     [Google Scholar]
  60. van ThielP.P. van der MeideW.F. van der SluisA. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.Am. J. Trop. Med. Hyg.20108361295130010.4269/ajtmh.2010.10‑0143 21118937
     [Google Scholar]
  61. AguadoM. EspinosaP. Romero-MatéA. TardíoJ.C. CórdobaS. BorbujoJ. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid.Actas Dermo-Sifiliográficas (English Edition).2013104433434210.1016/j.adengl.2013.03.005 23567452
     [Google Scholar]
  62. ""Chagas disease (American trypanosomiasis)".In: World Health Organization2019
     [Google Scholar]
  63. GuarnerJ. Chagas disease as example of a reemerging parasite.Semin. Diagn. Pathol.201936316416910.1053/j.semdp.2019.04.008 31006555
     [Google Scholar]
  64. BernC. Chagas’ disease.N. Engl. J. Med.2015373545646610.1056/NEJMra1410150 26222561
     [Google Scholar]
  65. ""DPDx – Trypanosomiasis, American. Fact Sheet".In: Centers for Disease Control (CDC).2019
     [Google Scholar]
  66. Pérez-MolinaJ.A. MolinaI. Chagas disease.Lancet201839110115829410.1016/S0140‑6736(17)31612‑4 28673423
     [Google Scholar]
  67. RobertsonL.J. DevleesschauwerB. Alarcón de NoyaB. Noya GonzálezO. TorgersonP.R. Trypanosoma cruzi: Time for international recognition as a foodborne parasite.PLoS Negl. Trop. Dis.2016106e000465610.1371/journal.pntd.0004656 27253136
     [Google Scholar]
  68. DespommierD.D. GriffinD.O. GwadzR.W. HotezP.J. KnirschC.A. American Trypanosomiasis.In: Parasitic Diseases.7th edNew YorkParasites Without Borders20197184
     [Google Scholar]
  69. BainB.J. Blood Cells: A Practical Guide.John Wiley & Sons2015165167
     [Google Scholar]
  70. BernC. MessengerL.A. WhitmanJ.D. MaguireJ.H. Chagas disease in the united states: A public health approach.Clin. Microbiol. Rev.201933110.1128/CMR.00023‑19
     [Google Scholar]
  71. SchijmanA.G. Molecular diagnosis of Trypanosoma cruzi.Clin. Microbiol. Rev.201833110.1016/j.actatropica.2018.02.019
     [Google Scholar]
  72. LuquettiA.O. SchijmanA.G. Switzerland: Springer Nature Diagnosis of Chagas diseaseIn: Chagas Disease: A Clinical Approach. 20191415810.1007/978‑3‑030‑00054‑7_7
     [Google Scholar]
  73. AnghebenA. BuonfrateD. CrucianiM. Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis.PLoS Negl. Trop. Dis.2019135e000727110.1371/journal.pntd.0007271 31150377
     [Google Scholar]
  74. Mougabure-CuetoG. PicolloM.I. Insecticide resistance in vector Chagas disease: Evolution, mechanisms and management.Acta Trop.2015149708510.1016/j.actatropica.2015.05.014 26003952
     [Google Scholar]
  75. AnghebenA. BoixL. BuonfrateD. Chagas disease and transfusion medicine: A perspective from non-endemic countries.Blood Transfus.201513454055010.2450/2015.0040‑15 26513769
     [Google Scholar]
  76. SantiA.M.M. MurtaS.M.F. Antioxidant defence system as a rational target for chagas disease and leishmaniasis chemotherapy.Mem. Inst. Oswaldo Cruz2022117e21040110.1590/0074‑02760210401 35239945
     [Google Scholar]
  77. RibeiroV. DiasN. PaivaT. Current trends in the pharmacological management of Chagas disease.Int. J. Parasitol. Drugs Drug Resist.20201271710.1016/j.ijpddr.2019.11.004 31862616
     [Google Scholar]
  78. NunesM.C.P. BeatonA. AcquatellaH. American heart association rheumatic fever, endocarditis and kawasaki disease committee of the council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; and stroke council.chagas cardiomyopathy: An update of current clinical knowledge and management: A scientific statement from the american heart association.Circulation201813812e169e20910.1161/CIR.0000000000000599 30354432
     [Google Scholar]
  79. LidaniK.C.F. AndradeF.A. BaviaL. Chagas disease: From discovery to a worldwide health problem.Front. Public Health2019716610.3389/fpubh.2019.00166 31312626
     [Google Scholar]
  80. LeeB.Y. BaconK.M. BottazziM.E. HotezP.J. Global economic burden of Chagas disease: A computational simulation model.Lancet Infect. Dis.201313434234810.1016/S1473‑3099(13)70002‑1 23395248
     [Google Scholar]
  81. Alonso-PadillaJ. PinazoM.J. GascónJ. Chagas Disease: A Clinical Approach.In: Chagas disease in EuropeSwitzerland: Springer Nature20191112310.1007/978‑3‑030‑00054‑7_5
     [Google Scholar]
  82. VelascoM. Gimeno-FeliúL.A. MolinaI. Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the spanish society of infectious diseases and clinical microbiology.Euro Surveill.2020258190039310.2807/1560‑7917.ES.2020.25.8.1900393 32127121
     [Google Scholar]
  83. DeeksE.D. Fexinidazole: First global approval.Drugs (Review)201979221522010.1007/s40265‑019‑1051‑6
     [Google Scholar]
  84. VermelhoA.B. RodriguesG.C. SupuranC.T. Why hasn’t there been more progress in new Chagas disease drug discovery?Expert Opin. Drug Discov.202015214515810.1080/17460441.2020.1681394 31670987
     [Google Scholar]
  85. KratzJ.M. Drug discovery for chagas disease: A viewpoint.Acta Trop.201919810510710.1016/j.actatropica.2019.105107 31351074
     [Google Scholar]
  86. RiosL.E. Vázquez-ChagoyánJ.C. PachecoA.O. ZagoM.P. GargN.J. Immunity and vaccine development efforts against Trypanosoma cruzi.Acta Trop.201920010516810.1016/j.actatropica.2019.105168 31513763
     [Google Scholar]
  87. BalouzV. AgüeroF. BuscagliaC.A. Chagas disease diagnostic applications: Present knowledge and future steps.Adv. Parasitol.20179714510.1016/bs.apar.2016.10.001 28325368
     [Google Scholar]
  88. DiasJ.C.P. Evolution of Chagas disease screening programs and control programs: Historical perspective.Glob. Heart201510319320210.1016/j.gheart.2015.06.003 26407516
     [Google Scholar]
  89. HotezP.J. FenwickA. MolyneuxD.H. Collateral benefits of preventive chemotherapy expanding the war on neglected tropical diseases.N. Engl. J. Med.2019380252389239110.1056/NEJMp1900400 31067365
     [Google Scholar]
  90. World Health OrganizationDracunculiasis eradication: intensifying surveillance amid continued zero human cases in Ethiopia and Mali2021https://www.who.int/news/item/19-03-2020-dracunculiasis-eradication-intensifying-surveillance-amid-continued-zero-human-cases-in-ethiopia-and-mali
  91. DurrantC. ThieleE.A. HolroydN. Population genomic evidence that human and animal infections in Africa come from the same populations of dracunculus medinensis.PLoS Negl. Trop. Dis.20201411e000862310.1371/journal.pntd.0008623 33253172
     [Google Scholar]
  92. HotezP. AksoyS. PLOS neglected tropical diseases: Ten years of progress in neglected tropical disease control and elimination … more or less.PLoS Negl. Trop. Dis.2017114e000535510.1371/journal.pntd.0005355 28426662
     [Google Scholar]
  93. MiltonP. HamleyJ.I.D. WalkerM. BasáñezM.G. Moxidectin: An oral treatment for human onchocerciasis.Expert Rev. Anti Infect. Ther.202018111067108110.1080/14787210.2020.1792772 32715787
     [Google Scholar]
  94. MitjàO. HaysR. IpaiA. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: An open-label, non-inferiority, randomised trial.Lancet2012379981334234710.1016/S0140‑6736(11)61624‑3 22240407
     [Google Scholar]
  95. HolmesA. TildesleyM.J. SolomonA.W. Modeling treatment strategies to inform yaws eradication.Emerg. Infect. Dis.202026112685269310.3201/eid2611.191491 33079046
     [Google Scholar]
  96. CasulliA. Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis.Lancet Glob. Health202084e470e47110.1016/S2214‑109X(20)30066‑8 32199112
     [Google Scholar]
  97. RossiP. TamarozziF. GalatiF. ERCE network.The european register of cystic echinococcosis, ERCE: State-of-the-art five years after its launch.Parasit. Vectors202013123610.1186/s13071‑020‑04101‑6 32381109
     [Google Scholar]
  98. CraigP.S. HegglinD. LightowlersM.W. TorgersonP.R. WangQ. Echinococcosis.Adv. Parasitol.2017965515810.1016/bs.apar.2016.09.002 28212791
     [Google Scholar]
  99. WHOIntegrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseaseshttp://www.who.int/neglected_diseases/meeting_reports/en/
  100. KantL. Deleting the ‘neglect’ from two neglected tropical diseases in India.Indian J. Med. Res.2016143439840010.4103/0971‑5916.184299 27377493
     [Google Scholar]
  101. HotezP.J. AlvaradoM. BasáñezM.G. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.PLoS Negl. Trop. Dis.201487e286510.1371/journal.pntd.0002865 25058013
     [Google Scholar]
  102. HotezP.J. PecoulB. RijalS. BoehmeC. AksoyS. MalecelaM. Eliminating the neglected tropical diseases: Translational science and new technologies.PLoS Negl. Trop. Dis.2016103e000389510.1371/journal.Pntd.000389
     [Google Scholar]
  103. LoboD.A. VelayudhanR. ChatterjeeP. KohliH. HotezP.J. The neglected tropical diseases of India and south Asia: Review of their prevalence, distribution, and control or elimination.PLoS Negl. Trop. Dis.2011510e122210.1371/journal.pntd.0001222 22039553
     [Google Scholar]
  104. World Health OrganizationNeglected tropical diseases. Geneva: World Health Organization2024
     [Google Scholar]
  105. World Health OrganizationEnding the neglect to attain the sustainable development goals—a road map for neglected tropical diseases 2021–2030.GenevaWorld Health Organization2021196
     [Google Scholar]
/content/journals/iddt/10.2174/0118715265305007240718081727
Loading
A Review on the Epidemiology and Clinical Management of Neglected Tropical Diseases
Infect. Disord. Drug Targets 25, E18715265305007 (2025); https://doi.org/10.2174/0118715265305007240718081727
/content/journals/iddt/10.2174/0118715265305007240718081727
/content/journals/iddt/10.2174/0118715265305007240718081727
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): epidemiological; infection; Neglected tropical diseases; pathogenesis; therapeutics; therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test